aspirin has been researched along with Auricular Flutter in 19 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valves and atrial fibrillation or flutter remain uncertain." | 9.41 | A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial. ( Almeida, AP; Ardito, RV; Atik, FA; Barreto, DO; Berwanger, O; Campos, VB; Cavalcante, MA; Cavalcanti, AB; D'Oliveira Vieira, R; Damiani, L; de Barros E Silva, PGM; de Lima, CEB; de Souza Neto, JD; Dos Santos, JRY; Farias, FR; Ferreira, JFM; Figueira, FAMS; Fonseca, FH; Guimarães, HP; Hoffmann-Filho, CR; Junior, RA; Kalil, PSA; Kojima, F; Lamprea, D; Laranjeira, L; Leiria, TLL; Liporace, IL; Lopes, RD; Magalhães, CC; Maldonado, JGA; Mesas, CE; Moisés, VA; Nakagawa, RH; Paiva, MSMO; Paixão, M; Patriota, R; Pavanello, R; Pinto, IM; Precoma, DB; Sampaio, BS; Sampaio, RO; Saraiva, JFK; Silveira, FS; Tarasoutchi, F; Zilli, AC, 2021) |
| "In this observational analysis of patients with atrial fibrillation and flutter, the concomitant use of direct oral anticoagulants and aspirin was associated with an increased risk of both major adverse cardiac and bleeding events when compared to the use of direct oral anticoagulants alone." | 7.96 | Concomitant use of direct oral anticoagulants and aspirin versus direct oral anticoagulants alone in atrial fibrillation and flutter: a retrospective cohort. ( George, J; Hafeez, A; Halalau, A; Keeney, S; Matka, M; Said, A, 2020) |
| "The efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valves and atrial fibrillation or flutter remain uncertain." | 5.41 | A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial. ( Almeida, AP; Ardito, RV; Atik, FA; Barreto, DO; Berwanger, O; Campos, VB; Cavalcante, MA; Cavalcanti, AB; D'Oliveira Vieira, R; Damiani, L; de Barros E Silva, PGM; de Lima, CEB; de Souza Neto, JD; Dos Santos, JRY; Farias, FR; Ferreira, JFM; Figueira, FAMS; Fonseca, FH; Guimarães, HP; Hoffmann-Filho, CR; Junior, RA; Kalil, PSA; Kojima, F; Lamprea, D; Laranjeira, L; Leiria, TLL; Liporace, IL; Lopes, RD; Magalhães, CC; Maldonado, JGA; Mesas, CE; Moisés, VA; Nakagawa, RH; Paiva, MSMO; Paixão, M; Patriota, R; Pavanello, R; Pinto, IM; Precoma, DB; Sampaio, BS; Sampaio, RO; Saraiva, JFK; Silveira, FS; Tarasoutchi, F; Zilli, AC, 2021) |
| "In this observational analysis of patients with atrial fibrillation and flutter, the concomitant use of direct oral anticoagulants and aspirin was associated with an increased risk of both major adverse cardiac and bleeding events when compared to the use of direct oral anticoagulants alone." | 3.96 | Concomitant use of direct oral anticoagulants and aspirin versus direct oral anticoagulants alone in atrial fibrillation and flutter: a retrospective cohort. ( George, J; Hafeez, A; Halalau, A; Keeney, S; Matka, M; Said, A, 2020) |
| " This man was promptly treated with aspirin 300 mg one time per day, as per the stroke pathway." | 3.91 | Bilateral paramedian pontine infarcts: a rare cause of bilateral horizontal gaze palsy. ( Bhandari, M; Chernov, D; Hassan, F; Karavassilis, ME, 2019) |
| " Ibrutinib use, age, hypertension, and previous use of ACE inhibitors, angiotensin receptor blocker use, β blocker use, and aspirin use were independently associated with incident arrhythmias." | 3.91 | Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic Chemotherapy. ( Armanious, M; Chavez, JC; Emole, J; Fradley, MG; Gliksman, M; Lee, DH; McLeod, H; Pinilla-Ibarz, J; Rhea, I; Schabath, MB; Shah, B; Viganego, F; Walko, C; Welter-Frost, A, 2019) |
| " Analysis of patient demographics and stroke risk identified trends in prescribing DOAC versus warfarin." | 3.83 | Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation. ( Baker, D; Narasimhan, S; Wilsmore, B, 2016) |
| "For patients with nonrheumatic AF, including those with paroxysmal AF, who are (1) at low risk of stroke (eg, CHADS(2) [congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischemic attack] score of 0), we suggest no therapy rather than antithrombotic therapy, and for patients choosing antithrombotic therapy, we suggest aspirin rather than oral anticoagulation or combination therapy with aspirin and clopidogrel; (2) at intermediate risk of stroke (eg, CHADS(2) score of 1), we recommend oral anticoagulation rather than no therapy, and we suggest oral anticoagulation rather than aspirin or combination therapy with aspirin and clopidogrel; and (3) at high risk of stroke (eg, CHADS(2) score of ≥ 2), we recommend oral anticoagulation rather than no therapy, aspirin, or combination therapy with aspirin and clopidogrel." | 3.78 | Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. ( Eckman, MH; Fang, MC; Go, AS; Halperin, JL; Howard, PA; Hughes, M; Hylek, EM; Lane, DA; Lip, GYH; Manning, WJ; Schulman, S; Singer, DE; Spencer, FA; You, JJ, 2012) |
| "Aspirin therapy has modest efficacy in reducing stroke risk, but is much less effective than warfarin." | 2.45 | Antithrombotic therapy for the treatment of atrial fibrillation in the elderly. ( Fang, MC, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Chernov, D | 1 |
| Karavassilis, ME | 1 |
| Hassan, F | 1 |
| Bhandari, M | 1 |
| Said, A | 1 |
| Keeney, S | 1 |
| Matka, M | 1 |
| Hafeez, A | 1 |
| George, J | 1 |
| Halalau, A | 1 |
| Guimarães, HP | 1 |
| de Barros E Silva, PGM | 1 |
| Liporace, IL | 1 |
| Sampaio, RO | 1 |
| Tarasoutchi, F | 1 |
| Paixão, M | 1 |
| Hoffmann-Filho, CR | 1 |
| Patriota, R | 1 |
| Leiria, TLL | 1 |
| Lamprea, D | 1 |
| Precoma, DB | 1 |
| Atik, FA | 1 |
| Silveira, FS | 1 |
| Farias, FR | 1 |
| Barreto, DO | 1 |
| Almeida, AP | 1 |
| Zilli, AC | 1 |
| de Souza Neto, JD | 1 |
| Cavalcante, MA | 1 |
| Figueira, FAMS | 1 |
| Junior, RA | 1 |
| Moisés, VA | 1 |
| Mesas, CE | 1 |
| Ardito, RV | 1 |
| Kalil, PSA | 1 |
| Paiva, MSMO | 1 |
| Maldonado, JGA | 1 |
| de Lima, CEB | 1 |
| D'Oliveira Vieira, R | 1 |
| Laranjeira, L | 1 |
| Kojima, F | 1 |
| Damiani, L | 1 |
| Nakagawa, RH | 1 |
| Dos Santos, JRY | 1 |
| Sampaio, BS | 1 |
| Campos, VB | 1 |
| Saraiva, JFK | 1 |
| Fonseca, FH | 1 |
| Pinto, IM | 1 |
| Magalhães, CC | 1 |
| Ferreira, JFM | 1 |
| Lopes, RD | 1 |
| Pavanello, R | 1 |
| Cavalcanti, AB | 1 |
| Berwanger, O | 1 |
| Lee, S | 1 |
| Je, NK | 1 |
| Fradley, MG | 1 |
| Gliksman, M | 1 |
| Emole, J | 1 |
| Viganego, F | 1 |
| Rhea, I | 1 |
| Welter-Frost, A | 1 |
| Armanious, M | 1 |
| Lee, DH | 1 |
| Walko, C | 1 |
| Shah, B | 1 |
| Chavez, JC | 1 |
| McLeod, H | 1 |
| Pinilla-Ibarz, J | 1 |
| Schabath, MB | 1 |
| Murthy, A | 1 |
| Murthy, AM | 1 |
| Jain, A | 1 |
| Tan, H | 1 |
| Baker, D | 1 |
| Wilsmore, B | 1 |
| Narasimhan, S | 1 |
| Fang, MC | 2 |
| Depta, JP | 1 |
| Cannon, CP | 1 |
| Fonarow, GC | 1 |
| Zhao, X | 1 |
| Peacock, WF | 1 |
| Bhatt, DL | 1 |
| You, JJ | 1 |
| Singer, DE | 1 |
| Howard, PA | 1 |
| Lane, DA | 1 |
| Eckman, MH | 1 |
| Hylek, EM | 1 |
| Schulman, S | 1 |
| Go, AS | 1 |
| Hughes, M | 1 |
| Spencer, FA | 1 |
| Manning, WJ | 1 |
| Halperin, JL | 1 |
| Lip, GYH | 1 |
| Ouali, S | 1 |
| Anselme, F | 1 |
| Savouré, A | 1 |
| Cribier, A | 1 |
| Diner, BM | 1 |
| Hochholzer, W | 1 |
| Schlittenhardt, D | 1 |
| Arentz, T | 1 |
| Stockinger, J | 1 |
| Weber, R | 1 |
| Bürkle, G | 1 |
| Kalusche, D | 1 |
| Trenk, D | 1 |
| Neumann, FJ | 1 |
| Wilber, DJ | 1 |
| Gunnar, RM | 1 |
| Köhler, U | 1 |
| Olsson, SB | 1 |
| Sharma, SN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase 2, Randomized, Open Label, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Rivaroxaban Compared With Vitamin K Antagonism in Patients With Atrial Fibrillation With Bioprosthetic Mitral Valves - RIVER[NCT02303795] | Phase 2 | 1,005 participants (Actual) | Interventional | 2015-08-31 | Completed | ||
| Comparison of Accidents and Their Circumstances With Oral Anticoagulants. The CACAO Study[NCT02376777] | 4,162 participants (Actual) | Observational | 2014-04-30 | Completed | |||
| Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation[NCT03021928] | Phase 3 | 200 participants (Actual) | Interventional | 2017-06-14 | Active, not recruiting | ||
| Anticoagulant-associated Intracranial Hemorrhage: Patient Characteristics and Outcomes From National Institute of Neurology and Neurosurgery Manuel Velasco: Single-Center Observational Study[NCT06168838] | 1,200 participants (Anticipated) | Observational | 2023-08-09 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for aspirin and Auricular Flutter
| Article | Year |
|---|---|
I've heard the terms "atrial flutter" and "atrial fibrillation" used interchangeably when describing certain heart-rhythm disorders, but I thought atrial flutter was a less-serious condition. Can you elaborate?
Topics: Anti-Arrhythmia Agents; Aspirin; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Diagnosis, | 2008 |
Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Flutter; Female; Fibrinolytic Agents; Human | 2009 |
Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Fl | 2003 |
1 trial available for aspirin and Auricular Flutter
| Article | Year |
|---|---|
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial.
Topics: Administration, Oral; Aspirin; Atrial Fibrillation; Atrial Flutter; Bioprosthesis; Brazil; Cause of | 2021 |
15 other studies available for aspirin and Auricular Flutter
| Article | Year |
|---|---|
Bilateral paramedian pontine infarcts: a rare cause of bilateral horizontal gaze palsy.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atrial Flutter; Brain; Cerebral Infarction; | 2019 |
Concomitant use of direct oral anticoagulants and aspirin versus direct oral anticoagulants alone in atrial fibrillation and flutter: a retrospective cohort.
Topics: Acute Coronary Syndrome; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; | 2020 |
Antithrombotic Therapy Underutilization in Patients With Atrial Flutter.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial | 2018 |
Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic Chemotherapy.
Topics: Adenine; Age Factors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibito | 2019 |
PCI patients taking oral anticoagulants may not need aspirin.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Clopidogrel; Drug Therapy, Combination | 2013 |
A not so benign atrial flutter: spontaneous 1:1 conduction of atrial flutter.
Topics: Adrenergic beta-Antagonists; Aspirin; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; D | 2013 |
Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation.
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutte | 2016 |
Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Anemia; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atri | 2009 |
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; | 2012 |
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; | 2012 |
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; | 2012 |
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; | 2012 |
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; | 2012 |
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; | 2012 |
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; | 2012 |
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; | 2012 |
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; | 2012 |
Acute coronary occlusion during radiofrequency catheter ablation of typical atrial flutter.
Topics: Acute Disease; Aged; Aspirin; Atrial Flutter; Catheter Ablation; Coronary Disease; Electrocardiograp | 2002 |
Platelet activation and myocardial necrosis in patients undergoing radiofrequency and cryoablation of isthmus-dependent atrial flutter.
Topics: Anticoagulants; Aspirin; Atrial Flutter; Biomarkers; Catheter Ablation; Chi-Square Distribution; Cry | 2007 |
Therapeutic options in atrial flutter and fibrillation.
Topics: Aged; Algorithms; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive | 1997 |
[Idiopathic atrial flutter].
Topics: Anti-Arrhythmia Agents; Aspirin; Atrial Fibrillation; Atrial Flutter; Cerebrovascular Disorders; Hum | 1998 |
Atrial fibrillation and flutter: aeromedical considerations. New strategies for management and intervention.
Topics: Aerospace Medicine; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flu | 1999 |
Atrial flutter in myocardial infarction.
Topics: Aspirin; Atrial Flutter; Digoxin; Electrocardiography; Furosemide; Humans; Isosorbide Dinitrate; Mal | 1992 |